Randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine and nanoparticle albumin-bound paclitaxel combination therapy as neoadjuvant chemotherapy for resectable/borderline resectable pancreatic ductal adenocarcinoma (PDAC-GS/GA-rP2, CSGO-HBP-015).

Daisaku YamadaShogo KobayashiHidenori TakahashiHirofumi AkitaTerumasa YamadaTadafumi AsaokaJunzo ShimizuYutaka TakedaShigekazu YokoyamaMasanori TsujieAkira TomokuniMasahiro TanemuraOsakuni MorimotoMasahiro MurakamiYongkook KimShin NakahiraNaoki HamaKeishi SugimotoKazuhiko HashimotoYuichiro DokiHidetoshi Eguchi

Published in: Trials (2021)

UMIN Clinical Trials Registry UMIN000021484 . This trial began in April 2016.

Keyphrases

locally advanced
combination therapy
phase ii study
neoadjuvant chemotherapy
phase iii
clinical trial
phase ii
open label
rectal cancer
double blind
squamous cell carcinoma
placebo controlled
radiation therapy
pet ct
sentinel lymph node
study protocol
randomized controlled trial
iron oxide
early stage